Jump to start of content

Breadcrumb trail:

Rheumatology Approval Committees

Longitudinal Knowledge Assessment 

Expand All | Collapse All

Marcy Bolster, MD, Chair

Dr. Bolster is an Associate Professor of Medicine at Harvard Medical School and Director, Rheumatology Fellowship Training Program, at Massachusetts General Hospital (MGH). With a strong interest in training and education Dr. Bolster has devoted her career to the training of rheumatology fellows, internal medicine residents and medical students. She values the importance of mentorship in her own professional development as well as through her commitment to sharing her dedication to patient care and education in the rheumatic diseases with learners at all stages of training. She has helped to train over 50 rheumatology fellows.

She has been the recipient of the American College of Rheumatology (ACR) Distinguished Program Director Award (2019) and the Mass General Brigham Program Director of the Year (2020). Among other medical education endeavors at MGH, Dr. Bolster is a member, of the Women in Medicine Trainees Council, an initiative to support professional development for women trainees and young faculty members through mentorship. She is a member of several MGH education committees and has teaching roles at Harvard Medical School.

Dr. Bolster has held leadership roles in ACR curriculum design and assessment, Accreditation Council for Graduate Medical Education Milestones, and the American Board of Internal Medicine (Rheumatology Specialty Board [2014-2020]; Council [2014-2020]; Chair, Rheumatology Exam Committee [2014-2018]; and Chair, Exam Chairs Committee [2015-2018]). She has served as Chair, ACR Committee on Training and Workforce (2012-2015) and had a leadership role in the graduate medical education component of the ACR Adult Rheumatology Workforce Study (2015). Dr. Bolster is ABIM Board certified in Rheumatology (1994, 2004, 2014).

She obtained her bachelor’s degree in chemistry and her medical degree from Duke University, Durham, North Carolina. She trained in internal medicine at the Eastern Virginia Graduate School of Medicine in Norfolk and obtained rheumatology training at Medical University of South Carolina in Charleston.

As of November 2021, Dr. Bolster reported the following external relationships:

Funding for clinical trial expenses and staff, paid to Harvard University, from the following companies:

  • Scleroderma trials
  • Genentech, for a COVID-19 clinical trial

Partial salary support for rheumatology fellows funded by educational grants from industry, paid to Harvard University, from the following companies:

  • Amgen
  • Pfizer
  • AbbVie
  • Janssen

Work as an author or editor for following companies, with compensation as listed:

  • Merck Manual, receiving compensation for authorship.
  • Association of Rheumatology Professionals, receiving compensation as associate editor.
  • PracticeUpdate, receiving compensation as associate editor.

Dr. Bolster serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • American College of Rheumatology, Committee on Marketing and Communications, Board of Directors, receiving reimbursement for travel expenses.

Grant funding for salary support, paid to Harvard University, from the following nonprofit healthcare-related organization:

  • Rheumatology Research Foundation, Clinician Scholar Educator Grant.

Thomas Mason, MD

Dr. Mason is currently board certified in Internal Medicine, Pediatrics, Rheumatology and Pediatric Rheumatology. He is an associate professor of medicine and pediatrics at Mayo Clinic Alix School of Medicine. He is the current Chair of the Division of Pediatric Rheumatology at Mayo Clinic Rochester, in Minnesota.

He has been practicing adult and pediatric rheumatology since 1993. He was the Director of the Rheumatology Fellowship Training Program from 1996 to 2015. He previously served on the American Board of Internal Medicine Rheumatology Board Exam Committee from 2009 to 2015.

Dr. Mason is a fellow of the American College of Rheumatology and member of the American Academy of Pediatrics.

Dr. Mason obtained a bachelor's degree in biology from West Virginia Wesleyan College in Buckhannon and is a graduate of West Virginia University Medical School in Morgantown. He trained in a combined internal medicine-pediatrics residency program at West Virginia University. He completed training in adult and pediatric rheumatology at the University of North Carolina at Chapel Hill.

As of April 2022, Dr. Mason reported no ongoing external relationship.

Kevin McKown, MD

Dr. McKown is an Emeritus Professor of Medicine at the University of Wisconsin School of Medicine and Public Health. He previously served as Head of the Division of Rheumatology (2007-2020) and Program Director of the Rheumatology Fellowship (2000-2019) in the Department of Medicine. Dr. McKown is ABIM Board Certified in Rheumatology (1992, 2002, 2012).

Prior to his position at the University of Wisconsin School of Medicine and Public Health, Dr. McKown was an Associate Professor of Medicine in the Division of Rheumatology at the University of Tennessee Health Science Center (UTHSC), where he was on faculty from 1992-2000. At the University of Tennessee, he served as Associate Chairman for Graduate Programs in the Department of Medicine, Program Director of the Internal Medicine Residency Program, and Co-Director of the Medicine-Neurology and Medicine-Pediatrics Residency Programs.

 Dr. McKown was a Councilor and President of the Alliance for Academic Internal Medicine Association of Specialty Professors. He served on the ABIM Rheumatology Examination Committee 2014-2020. His honors include the Alpha Omega Alpha Honor Medical Society, Best Doctors in America (2011-2020) and several teaching awards from both the University of Wisconsin School of Medicine and Public Health and the UTHSC.

Dr. McKown obtained a Bachelor of Science in Physiology from Michigan State University and Doctor of Medicine from Wayne State University. He received one year of training in Internal Medicine at Wayne State University, before serving as a Primary Care Medical Officer in the U.S. Navy. Dr. McKown completed his Internal Medicine training and his Rheumatology Fellowship at the UTHSC.

As of September 2021, Dr. McKown reported no ongoing external relationship.

Debendra Pattanaik, MD

Dr. Pattanaik, who is board certified in Internal Medicine, Rheumatology, Allergy and Immunology, is an associate professor (with tenure) of medicine in the Division of Rheumatology at the University of Tennessee Health Science Center in Memphis. He is the Director of the Rheumatology Fellowship Program. He also serves as the Site Director of the Allergy and Immunology Fellowship Program at the VA Medical Center, Memphis Tennessee.

Dr. Pattanaik is a fellow of the American College of Physicians, American College of Rheumatology (ACR) and American Academy of Allergy, Asthma and Immunology (AAAAI). During his career, he has served in the in-training examination committee of ACR. He is also a member of ACR's Continuing Assessment Review Evaluation (CARE) program. He chairs the AAAAI VHA Allergist committee and is a member of the AAAA's Adverse Reactions to Drugs Biologicals & Latex Committee.

He serves on the board of directors of Tennessee Rheumatism Society. Dr. Pattanaik is currently a member of the American Board of Internal Medicine Rheumatology Board Exam Committee.

Dr. Pattanaik received his medical degree (MBBS) from SCB Medical College, Cuttack India. He finished residency in internal medicine at John H. Stroger, Jr. Hospital of Cook County, Chicago followed by fellowship in allergy and clinical immunology at University of Rochester Medical Center, New York New York and fellowship in rheumatology at University of Texas Health Sciences Center, San Antonio.

As of October 2021, Dr. Pattanaik reported the following external relationships:

Dr. Pattanaik serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • American Academy of Allergy, Asthma, and Immunology, Chair, VA Committee, without compensation.
  • Tennessee Rheumatism Society, Secretary, without compensation.

Pascale Schwab, MD

Dr. Schwab is an associate professor at Oregon Health & Science University in the Division of Arthritis & Rheumatic Diseases. She has been the Director of the Rheumatology Fellowship Program since 2012. She is a staff rheumatologist at the VA Portland Health Care System. Previously, Dr. Schwab served as the Rheumatology Section Chief at the Portland VA for 7 years. She was a member of the American College of Rheumatology Workforce and Training Subcommittee on In-Training Exam.

Dr. Schwab completed medical school and her internal medicine residency training at the University of Texas Medical School in Houston where she also served as Chief Resident. She completed her fellowship training in Rheumatology at Brigham & Women’s Hospital/Harvard Medical School in Boston, Massachusetts.

As of April 2022, Dr. Schwab reported no ongoing external relationships.

Traditional, 10-Year MOC Exam

Expand All | Collapse All

Kenneth S. O'Rourke, MD, Chair

Kenneth S. O'Rourke, MD, ChairDr. O'Rourke, who is board certified in Internal Medicine and Rheumatology, is a Professor of Medicine at Wake Forest School of Medicine (WFSM). He is the Director of the Rheumatology Fellowship Training Program in the Section on Rheumatology and Immunology at WFSM (1995 to present).

Prior to his appointment at WFSM in 1992, Dr. O'Rourke was a lecturer in the Rheumatology Division of the Department of Internal Medicine at the University of Michigan (1991 to 1992). Prior to that position, he practiced general internal medicine in the United States Air Force (USAF) (1986 to 1989) and was the Program Director of the Transitional Year Residency at David Grant USAF Medical Center at Travis Air Force Base, California, while concurrently serving on the volunteer clinical faculty as Assistant Clinical Professor of Internal Medicine at the University of California, Davis (1987 to 1989).

Dr. O'Rourke is a fellow of the American College of Rheumatology (ACR) and member of the American College of Physicians. He is a member on the ACR's Curriculum Taskforce of the Committee on Education, and the Next Accreditation System Working Group of the Committee on Training and Workforce (COTW) that created the Rheumatology Entrustable Physician Activities and Rheumatology, Curricular Milestones. He currently serves as Chair of the American Board of Internal Medicine Rheumatology Board Exam Committee. He is a founding member of the Carolinas Fellows Collaborative, whose work has included the creation of a competency-based curriculum of goals, objectives and linked evaluations for rheumatology fellowship training programs. At WFSM, he has served on numerous education committees, including as Director of the second-year Musculoskeletal Block of the Systems Pathophysiology Course.

Dr O'Rourke obtained a bachelor's degree in bioengineering from the University of California, Berkeley. He trained in internal medicine at the David Grant USAF Medical Center and rheumatology training at the University of Michigan Medical Center.

As of June 2022, Dr. O’Rourke reported the following external relationship:

Dr. O’Rourke reported that he speaks for the American College of Rheumatology, receiving consulting fees.

Eliza F. Chakravarty, MD

Dr. Chakravarty is an Associate Member of the Oklahoma Medical Research Foundation, where she has an active clinical practice and a clinical research program focusing on pregnancy in women with autoimmune diseases. She is board certified in Rheumatology.

Previously, Dr. Chakravarty was an Assistant Professor of Medicine in the Division of Immunology at Stanford University School of Medicine in Palo Alto, California. During her time at Stanford, she served as Program Director for the Adult Rheumatology Fellowship program. Additionally, she served as an active member of the American College of Rheumatology Training and Workforce Committee. Currently, she serves as a member of the American Board of Internal Medicine Rheumatology Board Exam Committee.

Dr. Chakravarty received a bachelor's degree in chemistry and philosophy from New York University, a medical degree from the Johns Hopkins University and a master's degree in epidemiology from Stanford University. After completing internship, residency and Chief Residency in internal medicine at the Santa Clara Valley Medical Center in San Jose, California, she pursued fellowship training followed by an additional year of research training at Stanford University before joining the faculty in 2004.

As of April 2022, Dr. Chakravarty reported no ongoing external relationships.

Jennifer M. Grossman, MD

Jennifer M. Grossman, MDDr. Grossman is a Clinical Professor of Medicine in the Division of Rheumatology at the David Geffen School of Medicine at the University of California, Los Angeles (UCLA). She is also the Director of Lupus Clinical Research at UCLA and serves as the educational coordinator for rheumatology in the internal medicine residency training program. She is board certified in Rheumatology.

Dr. Grossman is a member of the American Board of Internal Medicine Rheumatology Board Exam Committee. She is also a member of the American College of Rheumatology (ACR) and has served on the ACR Guidelines subcommittee. Dr. Grossman has been involved in quality-of-care measurements in osteoporosis and systemic lupus erythematosus. She is a member of the Lupus Foundation of America's scientific advisory board and is also a board member of Lupus LA.

Dr. Grossman received her bachelor's degree in chemistry from Williams College and her medical degree from the University of Rochester. She completed her internal medicine residency and rheumatology fellowship at the UCLA Center for the Health Sciences. She joined the faculty there in 1998.

As of July 2020, Dr. Grossman reported the following external relationships.

Funding for clinical trial expenses, salary support and staff, paid to University of California at Los Angeles, from the following companies:

  • AstraZeneca, for a Phase 3 study of anifrolumab for lupus, and for a long-term extension study of anifrolumab for moderate to severe lupus.
  • Eli Lilly & Company, for a randomized control trial of baracitinib in moderate to severe lupus.
  • Lupus Clinic Trials Consortium, for establishment of a long-term observational systemic lupus erythematosus database.

Dr. Grossman serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • Lupus Foundation of America, Medical Scientific Advisory Board Member, without compensation.
  • Lupus LA, Medical Advisory Board Member, without compensation.

Funding for salary support, staff and expenses, paid to University of California at Los Angeles, from the following non-profit healthcare-related organizations:

  • Rheumatology Research Foundation, for a fellowship training grant.
  • National Institutes of Health, co-investigator on a colleague's R01 grant studying cardiovascular disease in a lupus cohort, receiving salary support.

Hilary M. Haftel, MD

Hilary M. Haftel, MDDr. Haftel is Professor of Pediatrics, Internal Medicine and Health Learning Sciences at the University of Michigan Medical School, where she has spent her entire academic career. She is Director of the Division of Pediatric Rheumatology and leads the Adolescent and Young Adult Rheumatology Program. She has been the Associate Chair and Director of Education in the Department of Pediatrics and Communicable Diseases at the University of Michigan since 2007, after serving as Assistant and then Associate Director of Pediatric Education for 11 years. Dr. Haftel served as Director of Communication Skills and Professionalism at the University of Michigan Medical School from 2003 to 2007. She is board certified in Rheumatology and Pediatric Rheumatology.

Dr. Haftel is recognized nationally for her work in undergraduate and graduate medical education. She serves as a member of the American Board of Internal Medicine Rheumatology Board Exam Committee. She is a member of the Association for Pediatric Program Directors (APPD) Longitudinal Education Assessment Research Network (LEARN) Advisory Council and serves as its Chair. Dr. Haftel is Council Member of the APPD's Leadership in Educational Academic Development (LEAD) program. She has been named as a “Best Doctor in America” as well as being among “America's Best Pediatricians.”

Dr. Haftel received a bachelor's degree in biology and music from Union College in Schenectady, New York and a medical degree from Albany Medical College in Albany, New York, where she also completed residency training in combined medicine-pediatrics and a chief residency before coming to the University of Michigan for fellowship training in adult and pediatric rheumatology in 1991. Dr. Haftel received a master's of health professions education degree from the University of Illinois at Chicago in 2004.

As of October 2021, Dr. Haftel reported the following external relationships:

Dr. Haftel serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • American Academy of Pediatrics, Senior Vice President for Education, receiving salary support.

Avis E. Ware, MD

Dr. Ware is ABIM Board Certified in Rheumatology; she is Professor of Medicine and Clinical Director of Rheumatology at the University of Cincinnati College of Medicine in Cincinnati, Ohio.

Dr. Ware obtained a bachelor's degree in music from Northwestern University in Evanston, Illinois, and her medical degree, from the University of Cincinnati College of Medicine. She completed her internal medicine residency training, from Christ Hospital in Cincinnati, Ohio. Dr. Ware had her fellowship training in Rheumatology at the University of Cincinnati College of Medicine and was the Program Director of the rheumatology training program at the University of Cincinnati College of Medicine.

As of August 2021, Dr. Ware reported no ongoing external relationships.